Newsroom

Health Professional Radio I OnQuality Pharmaceuticals – Phase 2 Cancer Supportive Care Therapy For

Dr. Michael McCullar, CEO, and Dr. Hong Tang, Chief Medical Officer at OnQuality Pharmaceuticals, a clinical stage pharma company...

Life Science Leader I Coming Out Of Stealth Mode: What To Know And Do

By Wayne Koberstein This article draws on the experience of five company CEOs with various backgrounds and views of stealth transitions....

OnQuality Pharmaceuticals Announces Upcoming Presentation at 2021 BIO Digital

SEATTLE, June 9, 2021 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted cancer supportive care company developing...

Clinical Trials Arena I OnQuality: developing treatments to combat cancer therapy side effects

By Kezia Parkins OnQuality’s chief medical officer and co-founder Hong Tang discusses the firm’s pipeline of cancer supportive care...

OnQuality Pharmaceuticals to Present on NOVA-II Trial Evaluating OQL011 at the 2021 ASCO and MASCC

OnQuality Pharmaceuticals to Present on NOVA-II Trial Evaluating OQL011 at the 2021 ASCO and MASCC/ISOO Annual Meetings SEATTLE, May 19,...

Prognosis Ohio | Relief for Cancer Patients: OSU's Dr. Benjamin Kaffenberger on an Ongoing Derma...

On the new Prognosis Ohio, part of the WCBE Podcast Experience, Dan Skinner talks with OSU dermatologist and researcher, Benjamin...

Empowered Patient I Targeted Cancer Supportive Care Agent for Skin Toxicities with OnQuality

By Karen Jagoda Michael McCullar, CEO and Hong Tang, Co-Founder and Chief Medical Officer OnQuality Pharmaceuticals describe the...

BioWorld | Onquality raises combined $35M for cancer supportive care pipeline

By David Ho HONG KONG – Onquality Pharmaceuticals LLC raised an additional $20 million from a series A+ financing round, bringing its...

WSJ Pro Venture Capital I VC Daily: Startups Use Technology to Help Drugmakers Bring More Diverse

By Brian Gormley Good day. Venture-backed companies are using technology to help drugmakers bring more diverse populations of patients...

OnQuality Pharmaceuticals Announces Closing of $35 Million Series A and A+ Financing

SEATTLE and SHANGHAI—March 31, 2021. OnQuality Pharmaceuticals LLC ("OnQuality"), a targeted cancer supportive care company developing me...